Oxidizable species as an internal reference in control solutions for biosensors

• US 8,702,926 B2
• Filed: 07/11/2011
• Issued: 04/22/2014
• Est. Priority Date: 04/08/2005
• Status: Active Grant

• Current Assignee: Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
• Original Assignee: Bayer Healthcare LLC (Bayer AG)
• Inventors: Beer, Greg P., Wu, Huan-Ping
• Primary Examiner(s): DIETERLE, JENNIFER M
• Application Number:
  US13/180,214
• Publication Number:
  US 20110262942A1
• Time in Patent Office: 1,016 Days
• Field of Search: 20440301-40315, 435/14, 435/287.1, 436 8- 19, 205/777.5, 205/778, 205/792, 422/68.1, 422/82.01, 600345-348
• US Class Current: 204/403.01
• CPC Class Codes: C12Q 1/004 mediator-assisted
• CPC Class Codes: G01N 27/3274 Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration coding of calibration information G01N33/48771
• CPC Class Codes: G01N 33/48707 by electrical means G01N33/49, G01N33/493 take precedence
• CPC Class Codes: G01N 33/49 Blood chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80
• CPC Class Codes: G01N 33/66 involving blood sugars, e.g. galactose
• CPC Class Codes: G01N 33/96 involving blood or serum control standard
• CPC Class Codes: Y10T 436/104998 Glucose, ketone, nitrate standard or control

Abstract

Testing of the performance of an electrochemical meter used to measure the presence of an analyte in a biological sample, particularly glucose in whole blood, includes introducing a control solution containing a predetermined amount of the analyte and a predetermined amount of an internal reference compound. The internal reference compound is selected such that it is oxidized at a potential greater than that used to oxidize the analyte, thereby making it possible to distinguish the control solution from a biological sample.

Claims

1. A control solution for use in testing an electrochemical system for measuring the amount of an analyte in a sample, the control solution comprising:

(a) a predetermined amount of said analyte; and

(b) a predetermined amount of an internal reference compound, said internal reference compound having a higher oxidation potential than said analyte, said predetermined amount of said internal reference compound being dependent upon said predetermined amount of analyte, the control solution being configured to be distinguished from the sample based on a Differential Index (DI), the predetermined amount of the internal reference compound being such that the control solution has a DI of at least 1.5, the DI being defined as DI=i_{high volt}/i_{low volt}

where;

i_{high volt} is an electrical current resulting from the application of a first potential sufficient to oxidize said internal reference compound and said analyte, and i_{low volt} is an electrical current resulting from the application of a second potential sufficient to oxidize said analyte and insufficient to oxidize said internal reference compound,

the second potential being applied before the first potential during the same period.

2. The control solution of claim 1, further comprising a buffer, the internal reference compound being different from the buffer, the internal reference compound and the buffer being configured to serve different functions.

3. The control solution of claim 1, wherein the second potential and the first potential are applied without a waiting period therebetween.

4. The control solution of claim 1, wherein said analyte is glucose and said sample is whole blood.

5. The control solution of claim 4, wherein the glucose is configured to be oxidized by glucose oxidase, the control solution further comprising a buffer to maintain pH between 5 and 7.

6. The control solution of claim 4, wherein the glucose is configured to be oxidized by glucose dehydrogenase, the control solution further comprising a buffer to maintain pH between 6 and 8.

7. The control solution of claim 4, wherein said internal reference compound is an oxidizable organo-metallic compound, coordination compound, or organic amine compound.

8. The control solution of claim 7, wherein said internal reference compound is said oxidizable organo-metallic compound, said oxidizable organo-metallic compound being ferrocene or ferrocene derivatives.

9. The control solution of claim 7, wherein said internal reference compound is said coordination compound, said coordination compound being potassium ferrocyanide.

10. The control solution of claim 7, wherein said internal reference compound is said organic amine compound, said organic amine compound being 3-(N-morpholino) propane sulfonic acid, N-(2-hydroxyethyl) piperazine-N¹-(2-ethane sulfonic acid), 2-[(2-Hydroxy-1,1-bis(hydroxy methyl)ethylamino]ethane sulfonic acid, 2-Morpholino ethane sulfonic acid, and Bis(2-hydroxyethyl)amino-tris(hydroxymethyl) methane [Bis-Tris], 4-aminobenzonitrile, 4-aminobenzoic acid, or 4-iodoaniline.

11. The control solution of claim 10, wherein said internal reference is Bis-Tris.